The Sacral Neuromodulation Market is estimated at US$2 billion in 2026 and is projected to grow at a CAGR of 11.4% to reach US$4.7 billion by 2034.
Core applications include overactive bladder management, urinary retention support, bowel dysfunction treatment, pelvic floor care, and specialty urology pathways. At the same time, suppliers must respond to procedure cost, reimbursement scrutiny, patient selection complexity, and competition from medication and alternative procedural options.
This product will be delivered within 1-3 business days.
Market Overview
The Sacral Neuromodulation Market covers implantable and external therapy systems that modulate sacral nerve activity to manage bladder, bowel, and related pelvic dysfunction conditions. Its value chain includes device component suppliers, neurostimulation manufacturers, hospitals, specialist clinics, surgical centers, reimbursement partners, and follow up care providers.Core applications include overactive bladder management, urinary retention support, bowel dysfunction treatment, pelvic floor care, and specialty urology pathways. At the same time, suppliers must respond to procedure cost, reimbursement scrutiny, patient selection complexity, and competition from medication and alternative procedural options.
Key Companies Analysed
- Medtronic
- Axonics
- Abbott
- LivaNova
- Boston Scientific
- Nevro
- Aleva Neurotherapeutics
- Neuspera Medical
- Cala Health
- ElectroCore
- Stimwave
- Nalu Medical
- MicroTransponder
- Saluda Medical
- Synapse Biomedical
- Mainstay Medical
- Neurosigma
- INSIDE Medical
- Bioinduction
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Sacral Neuromodulation Market Overview
3. Sacral Neuromodulation Market Dynamics
4. Sacral Neuromodulation Market Strategic Analysis
5. Global Sacral Neuromodulation Market Size, Share and Forecast, 2025-2034
6. North America Sacral Neuromodulation Market Outlook to 2034
7. Europe Sacral Neuromodulation Market Outlook to 2034
8. Asia-Pacific Sacral Neuromodulation Market Outlook to 2034
9. Middle East and Africa Sacral Neuromodulation Market Outlook to 2034
10. South and Central America Sacral Neuromodulation Market Outlook to 2034
11. Sacral Neuromodulation Market Competitive Landscape
12. Appendix
Companies Mentioned
- Medtronic
- Axonics
- Abbott
- LivaNova
- Boston Scientific
- Nevro
- Aleva Neurotherapeutics
- Neuspera Medical
- Cala Health
- ElectroCore
- Stimwave
- Nalu Medical
- MicroTransponder
- Saluda Medical
- Synapse Biomedical
- Mainstay Medical
- Neurosigma
- INSIDE Medical
- Bioinduction
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 2 Billion |
| Forecasted Market Value ( USD | $ 4.7 Billion |
| Compound Annual Growth Rate | 11.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
